With these two readouts, the company describes five Phase 3 retatrutide studies as positive
Indications and Usage for Vyvanse VYVANSE is indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see Clinical Studies (14.1)]
However, most of the studies showing it was of little benefit for various reasons were studies using non-liposomal forms of glutathione
The severity of symptoms from a traumatic brain injury usually depends on several factors, including the cause of the injury and the force of initial impact
Although cardiovascular risk has not been elevated in short-term trials, comprehensive long-term data are still pending
In the SELECT trial [27], however, ASCVD patients with overweight or obesity were already included with a BMI of 27kg/m 2 or higher